Natural cytotoxicity receptor (NCR) (family: includes NKp30, NKp44, NKp46) (NCR (for the family; NKp46, NKp44, NKp30 for individual members))

Natural cytotoxicity receptors (NCRs) are a family of activating receptors predominantly expressed on natural killer (NK) cells and include NKp46 (NCR1), NKp44 (NCR2), and NKp30 (NCR3). These receptors recognize stress-induced ligands or pathogen-derived molecules primarily on the surface of tumor cells or infected cells, leading to rapid NK cell activation, cytotoxic degranulation (perforin–granzyme pathway), and/or inducement of apoptosis through death ligands such as FasL or TRAIL[1][2][3][4][5]. The coordinated action of NCRs is essential for direct killing of tumors and infected cells, cytokine production, and immune surveillance. The diversity of NCR ligands, alternative receptor isoforms, and tumor evasion strategies highlight both the therapeutic potential and complexity of targeting these receptors in cancer immunotherapy and infectious disease[1][3][4][5]. Note: The queried "target" is incorrectly named as a pathway rather than an individual molecule or receptor. To obtain structured information for actual drug targets, search for one of the major NCR members by canonical name (e.g., "NKp46 (NCR1)", "NKp44 (NCR2)", "NKp30 (NCR3)").

Other names

NCRsnatural killer cell receptorsNKp46 (NCR1)NKp44 (NCR2)NKp30 (NCR3)natural cytotoxicity receptors

Enhancing NK cell activation and cytotoxicity by upregulating NCR expression or delivering activating signals through NCRs; Blocking inhibitory ligands or preventing NCR ligand shedding for sustained antitumor activity; Fusion of NCR signaling domains to chimeric antigen receptors (CARs) in cell therapy